Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors

about

Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors

Item

http://www.wikidata.org/entity/Q57099831

description

im Juli 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@en

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@nl

type

Item

label

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@en

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@nl

prefLabel

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@en

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@nl

P1476

Decrease of 5-hydroxymethylcyt ...... testinal neuroendocrine tumors

@en

P2093

Elham Barazeghi

http://www.w3.org/2001/XMLSchema#string

Olov Norlén

http://www.w3.org/2001/XMLSchema#string

Per Hellman

http://www.w3.org/2001/XMLSchema#string

Surendra Prabhawa

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Connections between TET proteins and aberrant DNA modification in cancer

Role of TET enzymes in DNA methylation, development, and cancer

The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.

P2888

s12885-018-4579-z

P304

764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4579-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Stålberg

Gunnar Westin

P577

2018-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105837184

http://www.w3.org/2001/XMLSchema#string

P698

30045709

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6060499

http://www.w3.org/2001/XMLSchema#string